Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bonedense CC is an oral dietary supplement developed by Liveon Healthcare, specifically formulated to address bone health deficiencies and meet the increased calcium requirements during pregnancy and lactation. The product is a combination of calcium citrate malate, cholecalciferol (Vitamin D3), folic acid, and zinc sulphate. Calcium citrate malate is utilized for its high bioavailability compared to other calcium salts, providing elemental calcium for bone mineralization. Cholecalciferol acts as an agonist at the Vitamin D receptor (VDR), facilitating the intestinal absorption of calcium and maintaining skeletal integrity. Folic acid is included to support maternal health and fetal development, while zinc serves as a cofactor for various bone-forming enzymes. It is primarily indicated for the prevention and management of osteoporosis and other bone density-related conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bonedense CC.